维普中文期刊产品整合服务
50篇 您的检索式:作者名="Murphy Mk"
    题名 作者 年代 出处 被引量
1Orally administered extract from Prunella vulgaris attenuates spontaneous colitis in mdr1a^(-/-) mice显示文摘AIM: To investigate the ability of a Prunella vulgaris(P. vulgaris) ethanolic extract to attenuate spontaneous typhlocolitis in mdr1a-/- mice. METHODS: Vehicle(5% ethanol) or P. vulgaris ethanolic extract(2.4 mg/d) were administered daily by oral gavage to mdr1a-/- or wild type FVBWT mice from 6 wk of age up to 20 wk of age. Clinical signs of disease were noted by monitoring weight loss. Mice experiencingweight loss in excess of 15% were removed from the study. At the time mice were removed from the study, blood and colon tissue were collected for analyses that included histological evaluation of lesions, inflammatory cytokine levels, and myeloperoxidase activity. RESULTS: Administration of P. vulgaris extracts to mdr1a-/- mice delayed onset of colitis and reduced severity of mucosal inflammation when compared to vehicle-treated mdr1a-/- mice. Oral administration of the P. vulgaris extract resulted in reduced(P < 0.05) serum levels of IL-10(4.6 ± 2 vs 19.4 ± 4), CXCL9(1319.0 ± 277 vs 3901.0 ± 858), and TNFα(9.9 ± 3 vs 14.8 ± 1) as well as reduced gene expression by more than two-fold for Ccl2, Ccl20, Cxcl1, Cxcl9, IL-1 α, Mmp10, VCAM-1, ICAM, IL-2, and TNFα in the colonic mucosa of mdr1a-/- mice compared to vehicle-treated mdr1a-/-mice. Histologically, several microscopic parameters were reduced(P < 0.05) in P. vulgaris-treated mdr1a-/-mice, as was myeloperoxidase activity in the colon(2.49 ± 0.16 vs 3.36 ± 0.06, P < 0.05). The numbers of CD4+ T cells(2031.9 ± 412.1 vs 5054.5 ± 809.5) and germinal center B cells(2749.6 ± 473.7 vs 4934.0 ± 645.9) observed in the cecal tonsils of P. vulgaris-treated mdr1a-/- were significantly reduced(P < 0.05) from vehicle-treated mdr1a-/- mice. Vehicle-treated mdr1a-/- mice were found to produce serum antibodies to antigens derived from members of the intestinal microbiota, indicative of severe colitis and a loss of adaptive tolerance to the members of the microbiota. These serum antibodies were greatly reduced or absent in P. vulgaris-treated mdr1a-/- mice. CONCLUSION: The anti-inflammatory activity of P. vulgaris ethanolic extract effectively attenuated the severity of intestinal inflammation in mdr1a-/- mice.Kelley MK Haarberg Meghan J Wymore Brand Anne-Marie C Overstreet Catherine C Hauck Patricia A Murphy Jesse M Hostetter Amanda E Ramer-Tait Michael J Wannemuehler 2015World Journal of Gastrointestinal Pharmacology and Therapeutics2015,6,4:8
2The natural history of amyotrophic lateral sclerosis显示文摘Ringel SP Murphy JR Alderson MK 1993Neurology1993,43,7:1
3TGF ~11, GDF 5, and BMP-2 stimulation induces chondrogenesis in expanded human articular chondrocytes and marrow derived stromal cells 显示文摘Murphy MK Huey DJ Hu JC 2015Stem Cells2015,33,3:1
4Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age显示文摘Alsamarai S Adams JM Murphy MK 2009J Clin Endocrinol Metab2009,94,12:1
5Temporomandibular disorders: a review of etiology, clinical management, and tissue cngineering strategies 显示文摘Murphy MK MacBarb RF Wong ME 2013lnt J Oral Maxillofac Implants2013,28,6:1
6Randomized phase Ⅲ evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the eastern ooperative oneology group 显示文摘Gibson MK Li Y Murphy B 2005Clin Oncol2005,23,15:1
7Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head andneck cancer (E1395) :an intergroup trial of the Eastern Cooperative Ontology Group 显示文摘Gibson MK Li Y Murphy B 2005J Clin Oncol2005,23,15:1
8Randomized phase Ⅲ evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395):an intergroup trial of the Eastern Cooperative Oncology Group显示文摘Gibson MK Li Y Murphy B 2005J Clin Oncol2005,23,15:1
9E- valuation of the new cesium-131 seed for use in low-energy X-ray brachytherapy 显示文摘Murphy MK Piper PK Greenwood LR 2004Medical Physics2004,31,6:1
10Filaggrin deficient mice exhibitThl7 - dominated skin inflammation and permissiveness to epicutaneoussensitization with protein antigen显示文摘Oyoshi MK Murphy GF Geha RS 2009J Allergy Clin Immunol2009,124,3:1
11Evaluation of the new cesium- 131 seed for use in low-energy X-ray brachytherapy 显示文摘Murphy MK Piper RK Greenwood LR 2004Medical Physics2004,31,4:1
12Craving as an alcohol use disorder symptom in DSM - 5 : an empirical examination in a treatment -seeking sample显示文摘Murphy CM Stojek MK Few LR 2014Exp Clin Psychopharm2014,22,:1
13Consensus development methods and their use in clinical guideline development显示文摘 Black N Lamping DL 1998Health Technology Assessment1998,2,3:1
14Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group 显示文摘Gibson MK Li Y Murphy B 2005J Clin Oncol2005,23,15:1
15Embolization of bronchial arteries with N- butyl cyanoacrylate for management of massive hemoptysis: a technical review显示文摘Razavi MK Murphy K 2007Tech Vasc Interv Radiol2007,10,:1
16Randomized phase Ⅲ evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395):an Intergroup trial of the Eastern Cooperative Oncology Group显示文摘 Li Y Murphy B 2005J Clin Oncol2005,23,:1
17The natural history of amyotrophic lateral sclerosis 显示文摘Ringel SP Murphy JR Alderson MK 1993Neurology1993,43,7:1
18Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age 显示文摘Alsamarai S Adams JM Murphy MK 2009J Clin Endocrinol Metab2009,94,12:1
19Evalua- tion of the new cesium-131 seed for use in low-energy X-ray brachytherapy显示文摘Murphy MK Piper RK Greenwood LR 2004Medical Physics2004,31,4:1
20Unconjugated hilirubin in human bile:the nucleating factor in cholesterol cholelithiasis? 显示文摘Dutt MK Murphy GM Thompson RP 2003J Clin Pathol2003,56,8:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费